UNITED CAPITAL FINANCIAL ADVISORS, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 123 filers reported holding TG THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
UNITED CAPITAL FINANCIAL ADVISORS, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$3,326,000
-7.4%
69,010
+0.0%
0.02%
-18.2%
Q4 2020$3,590,000
+124.1%
69,005
+15.3%
0.02%
+120.0%
Q3 2020$1,602,000
+36.8%
59,865
-0.4%
0.01%
+11.1%
Q2 2020$1,171,000
+114.9%
60,110
+8.6%
0.01%
+80.0%
Q1 2020$545,000
-11.2%
55,3600.0%0.01%
+25.0%
Q4 2019$614,000
+94.3%
55,360
-1.8%
0.00%
+100.0%
Q3 2019$316,000
-34.7%
56,400
+0.7%
0.00%
-33.3%
Q2 2019$484,000
+10.0%
56,000
-5.1%
0.00%0.0%
Q1 2019$440,000
+57.7%
59,000
-13.4%
0.00%
+50.0%
Q4 2018$279,000
+136.4%
68,100
+222.7%
0.00%
+100.0%
Q3 2018$118,000
-86.4%
21,100
-68.0%
0.00%
-83.3%
Q2 2018$868,000
+22.3%
66,000
+32.0%
0.01%
+20.0%
Q1 2018$710,000
+29.6%
50,000
-25.2%
0.01%
+25.0%
Q4 2017$548,000
-20.3%
66,885
+15.2%
0.00%
-33.3%
Q3 2017$688,000
+18.0%
58,0500.0%0.01%
+20.0%
Q2 2017$583,000
+24.8%
58,050
+44.9%
0.01%
+25.0%
Q1 2017$467,00040,0500.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders